Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C27H25ClN2O4 |
| Molecular Weight | 476.951 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC2(COC(=O)C1=CC=C(Cl)C=C1)C(=O)N(N(C2=O)C3=CC=CC=C3)C4=CC=CC=C4
InChI
InChIKey=OZKQTMYKYQGCME-UHFFFAOYSA-N
InChI=1S/C27H25ClN2O4/c1-2-3-18-27(19-34-24(31)20-14-16-21(28)17-15-20)25(32)29(22-10-6-4-7-11-22)30(26(27)33)23-12-8-5-9-13-23/h4-17H,2-3,18-19H2,1H3
| Molecular Formula | C27H25ClN2O4 |
| Molecular Weight | 476.951 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Feclobuzone (AE9) is one of the pyrazolone series of cyclooxygenase inhibitors with NSAID analgesic, antiinflammatory and antipyretic activities. Feclobuzone is a potential binding molecule of 3C-like proteinase of severe acute respiratory syndrome coronavirus as identified by virtual screening.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:24:36 GMT 2025
by
admin
on
Mon Mar 31 21:24:36 GMT 2025
|
| Record UNII |
R6889JIL5D
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Mon Mar 31 21:24:36 GMT 2025 , Edited by admin on Mon Mar 31 21:24:36 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1138
Created by
admin on Mon Mar 31 21:24:36 GMT 2025 , Edited by admin on Mon Mar 31 21:24:36 GMT 2025
|
PRIMARY | |||
|
R6889JIL5D
Created by
admin on Mon Mar 31 21:24:36 GMT 2025 , Edited by admin on Mon Mar 31 21:24:36 GMT 2025
|
PRIMARY | |||
|
100000081788
Created by
admin on Mon Mar 31 21:24:36 GMT 2025 , Edited by admin on Mon Mar 31 21:24:36 GMT 2025
|
PRIMARY | |||
|
R6889JIL5D
Created by
admin on Mon Mar 31 21:24:36 GMT 2025 , Edited by admin on Mon Mar 31 21:24:36 GMT 2025
|
PRIMARY | |||
|
176165
Created by
admin on Mon Mar 31 21:24:36 GMT 2025 , Edited by admin on Mon Mar 31 21:24:36 GMT 2025
|
PRIMARY | |||
|
C65631
Created by
admin on Mon Mar 31 21:24:36 GMT 2025 , Edited by admin on Mon Mar 31 21:24:36 GMT 2025
|
PRIMARY | |||
|
DTXSID70177677
Created by
admin on Mon Mar 31 21:24:36 GMT 2025 , Edited by admin on Mon Mar 31 21:24:36 GMT 2025
|
PRIMARY | |||
|
SUB07523MIG
Created by
admin on Mon Mar 31 21:24:36 GMT 2025 , Edited by admin on Mon Mar 31 21:24:36 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104250
Created by
admin on Mon Mar 31 21:24:36 GMT 2025 , Edited by admin on Mon Mar 31 21:24:36 GMT 2025
|
PRIMARY | |||
|
3187
Created by
admin on Mon Mar 31 21:24:36 GMT 2025 , Edited by admin on Mon Mar 31 21:24:36 GMT 2025
|
PRIMARY | |||
|
23111-34-4
Created by
admin on Mon Mar 31 21:24:36 GMT 2025 , Edited by admin on Mon Mar 31 21:24:36 GMT 2025
|
PRIMARY | |||
|
2391141
Created by
admin on Mon Mar 31 21:24:36 GMT 2025 , Edited by admin on Mon Mar 31 21:24:36 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
